Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,723
  • Shares Outstanding, K 6,422
  • Annual Sales, $ 124,960 K
  • Annual Income, $ -21,580 K
  • EBIT $ 14 M
  • EBITDA $ 41 M
  • 60-Month Beta 0.61
  • Price/Sales 0.53
  • Price/Cash Flow 15.12
  • Price/Book 0.68

Options Overview Details

View History
  • Implied Volatility 333.66% (+70.93%)
  • Historical Volatility 59.18%
  • IV Percentile 87%
  • IV Rank 38.77%
  • IV High 748.29% on 12/23/25
  • IV Low 71.16% on 08/12/25
  • Expected Move (DTE 32) 4.25 (37.02%)
  • Put/Call Vol Ratio 0.67
  • Today's Volume 85
  • Volume Avg (30-Day) 112
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 7,264
  • Open Int (30-Day) 9,895
  • Expected Range 7.23 to 15.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -3.05
  • Number of Estimates 1
  • High Estimate -3.05
  • Low Estimate -3.05
  • Prior Year -1.65
  • Growth Rate Est. (year over year) -84.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.61 +33.33%
on 12/31/25
11.62 -1.20%
on 01/16/26
+0.48 (+4.35%)
since 12/16/25
3-Month
8.61 +33.33%
on 12/31/25
14.25 -19.44%
on 11/11/25
-0.88 (-7.13%)
since 10/16/25
52-Week
7.65 +50.07%
on 04/09/25
15.15 -24.22%
on 09/18/25
-0.59 (-4.87%)
since 01/16/25

Most Recent Stories

More News
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained...

ASRT : 11.48 (+3.14%)
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Peer-reviewed publication in “The Oncologist” is now available online Investigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event...

ASRT : 11.48 (+3.14%)
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it filed a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”)...

ASRT : 11.48 (+3.14%)
Assertio: Q3 Earnings Snapshot

Assertio: Q3 Earnings Snapshot

ASRT : 11.48 (+3.14%)
Assertio Reports Third Quarter 2025 Financial Results

Advanced Integration Efforts to Consolidate Subsidiaries and Pulled Forward Two Quarters of Rolvedon Demand Promotes Paul Schwichtenberg to President...

ASRT : 11.48 (+3.14%)
Assertio Announces Leadership Transition

Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within...

ASRT : 11.48 (+3.14%)
Assertio Therapeutics Amends ROLVEDON Supply Agreement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Assertio...

ASRT : 11.48 (+3.14%)
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025

PHILADELPHIA , Sept. 23, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against  Spectrum...

ASRT : 11.48 (+3.14%)
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

New data show how Sympazan is being used in daily clinical practice to treat patients with Lennox-Gastaut Syndrome (LGS), a severe form of childhood-onset epilepsy Study addresses lack of awareness and...

ASRT : 11.48 (+3.14%)
DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025

PHILADELPHIA , Sept. 12, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  is investigating securities fraud claims against  Spectrum...

ASRT : 11.48 (+3.14%)

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 12.75
2nd Resistance Point 12.19
1st Resistance Point 11.83
Last Price 11.48
1st Support Level 10.91
2nd Support Level 10.35
3rd Support Level 9.99

See More

52-Week High 15.15
Fibonacci 61.8% 12.28
Last Price 11.48
Fibonacci 50% 11.40
Fibonacci 38.2% 10.51
52-Week Low 7.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar